Changes in insulin sensitivity in morbidly obese patients with or without metabolic syndrome after gastric bypass

Obesity Surgery

Volumn 16, Issue 11, 2006, Pages 1520-1525

  Coppini, Luciana Zuolo ^a,b   Bertevello, Pedro Luiz ^a   Gama Rodrigues, Joaquim ^a   Waitzberg, Dan Linetzky ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b NONE   (Brazil)

Author keywords

Gastric bypass; Insulin resistance; Metabolic syndrome; Morbid obesity; Roux en y anastomosis

Indexed keywords

CARBOHYDRATE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIPID;

ADULT; AGED; ANTHROPOMETRY; ARTICLE; BODY COMPOSITION; CLINICAL ARTICLE; CLINICAL FEATURE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; HYPERTRIGLYCERIDEMIA; INSULIN SENSITIVITY; INSULINEMIA; LONGITUDINAL STUDY; MALE; METABOLIC SYNDROME X; MORBID OBESITY; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; ROUX Y ANASTOMOSIS; STOMACH BYPASS; VASCULAR RESISTANCE;

ADOLESCENT; ADULT; AGED; BLOOD GLUCOSE; BODY MASS INDEX; CASE-CONTROL STUDIES; FEMALE; GASTRIC BYPASS; HUMANS; INSULIN; INSULIN RESISTANCE; LIPIDS; LONGITUDINAL STUDIES; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY, MORBID;

EID: 33751070475     PISSN: 09608923     EISSN: None     Source Type: Journal    
DOI: 10.1381/096089206778870030     Document Type: Article

References (28)

1. Buchwald H, Williams SE. Bariatric surgery worldwide 2003. Obes Surg 2004; 14: 1157-64.
2. l° Simpósio Pontos Relevantes em Obesidade - Ibge (Instittuto Brasileiro Geográfico Estatístico), 2001.
3. Defronzo RA, Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia and atherosclerotic cardiovascular disease. Diabetes Care 1991; 14: 173-94.
4. Reaven G.M. Role of insulin resistance in human disease. Diabetes 1988; 37: 1495.
5. McLaughlin T, Abbasi F, Kim HS et al. Relationships between insulin resistance, weight loss, and coronary heart disease risk in healthy, obese women. Metabolism 2001; 50: 795-800.
6. Capella RF, Capella J. Reducing early technical complications in gastric bypass surgery. Obes Surg 1997; 7: 149-57.
7. Fobi MAL, Lee H, Felahy B et al. Choosing an operation for weight control, and the transected banded gastric bypass. Obes Surg 2005; 15: 114-21.
8. Gastrointestinal surgery for severe obesity. National Institutes of Health Consensus Development Conference Draft Statement. Obes Surg 1991; 1: 257-65.
9. Executive summary of third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-97.
10. Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications. Report of a World Health Organization Consultation. Geneva, Switzerland, WHO, 1997.
11. Bioelectrical impedance analysis in body composition measurement. National Institutes of Health. Technology Assessment Conference Statement. Am J Clin Nutr 1996; 64: 524S.
12. Dietpro 4 - Sistema de Suporte e Avaliação Nutricional e Prescrição de dictas. Agromídia Software Ltda. Viçosa. MG Brazil, 2004.
13. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Follow-Up Report on the Diagnosis of Diabetes Mellitus. Diabetes Care 2003; 26: 3160-7.
14. Matthews D, Hosker J, Rudensk A et al. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentration in man. Diabetologia 1985; 20: 1087-92.
15. Faintuch J, Matsuda M, Cruz Melf et al. Severe protein-caloric malnutrition after bariatric procedures. Obes Surg 2004; 14: 175-81.
16. Ballantyne GH. Measuring outcomes following bariatric surgery: weight loss parameters, improvement in co-morbid conditions, change in quality of life and patient satisfaction. Obes Surg 2003; 13: 954-64.
17. Higa KD, Boone K, Ho T et al. Complications of the laparoscopic Roux-en-Y gastric bypass: 1,040 patients - what have we learned? Obes Surg 2000; 10: 509-13.
18. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: The evidence report. National Heart. Lung and Blood Institute. Obes Res 1998; 6 (Suppl 2): 51S-209S.
19. Laasko M. How good a marker is insulin level for insulin resistance? Am J Epidemiol 1993; 137: 959-65.
20. Bonora E, Formentini G, Calcaterra F et al. HOMA-estimated insulin resistance is an independent predictor of cardiovascular disease in type 2 diabetic subjects. Diabetes Care 2002; 23: 57-63.
21. Després JP, Moorjani S, Lupien PJ et al. Regional distributions of body fat plasma, lipoproteins and cardiovascular disease. Arteriosclerosis 1990; 10: 497.
22. Sjostrom L, Lindroos AK, Peltonen M et al. Lifestyle, diabetes and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 2004; 351: 2683-93.
23. Krysztof P, Jaroslaw K, Stanowski E. Vertical banded gastroplasty: 6 years experience at a center in Poland. Obes Surg 2005; 15: 223-7.
24. Moize V, Gelieber A, Gluck ME et al. Obese patients have inadequate protein intake related to protein intolerance up to 1 year following Roux-en-Y gastric bypass. Obes Surg 2003; 13: 23-8.
25. Coughlin K, Bell RM, Bivins GA et al. Preoperative and postoperative assessment of nutrient intake in patients who have undergone gastric bypass surgery. Arch Surg 1983; 118: 813-6.
26. Brolin RE, Robertson LB, Kenler HA et al. Weight loss and dietary intake after vertical banded gastroplasty and Roux-en-Y gastric bypass. Ann Surg 1994; 220: 782-90.
27. Giusti V, Suter M, Heraief E et al. Effects of laparoscopic gastric banding on body composition, metabolic profile and nutritional status of obese women: 12 months follow-up. Obes Surg 2004; 14: 239-45.
28. Wardé-Kamar J, Rogers M, Flancbaum L et al. Caloric intake and meal patterns up to 4 years after Roux-en-Y gastric bypass surgery. Obes Surg 2004; 14: 1070-9.